T cell costimulatory and coinhibitory pathways in vascular inflammatory diseases

Frontiers in Physiology

Volumn 3 FEB, Issue , 2012, Pages

  Lichtman, Andrew H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Coinhibition, T cells; Costimulation; Dendritic cells; Macrophages vascular disease

Indexed keywords

EID: 84866296781     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00018     Document Type: Review

References (88)

1. Abbas, A. K., Lichtman, A. H., and Pil-lai, S. (2011). Cellular and Molecular Immunology, 7th Edn. Philadephia: Elsevier, Inc.
2. Afek, A., Harats, D., Roth, A., Keren, G., and George, J. (2005). A functional role for inducible costimula-tor (ICOS) in atherosclerosis. Atherosclerosis 183, 57-63.
3. Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A. K., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., Flavell, R. A., Hansson, G. K., Klatzmann, D., Tedgui, A., and Mallat, Z. (2006). Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178-180.
4. Angeli, V., Llodra, J., Rong, J. X., Satoh, K., Ishii, S., Shimizu, T., Fisher, E. A., and Randolph, G. J. (2004). Dyslipi-demia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21, 561-574.
5. Bae, Y. S., Lee, J. H., Choi, S. H., Kim, S., Almazan, F., Witztum, J. L., and Miller, Y. I. (2009). Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ. Res. 104, 210-218.
6. Boesteanu, A. C., and Katsikis, P. D. (2009). Memory T cells need CD28 costimulation to remember. Semin. Immunol. 21, 69-77.
7. Bour-Jordan, H., Esensten, J. H., Martinez-Llordella, M., Penaranda, C., Stumpf, M., and Bluestone, J. A. (2011). Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol. Rev. 241, 180-205.
8. Bour-Jordan, H., Salomon, B. L., Thompson, H. L., Szot, G. L., Bern-hard, M. R., and Bluestone, J. A. (2004). Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J. Clin. Invest. 114, 979-987.
9. Bu, D. X., Tarrio, M., Maganto-Garcia, E., Stavrakis, G., Tajima, G., Lederer, J., Jarolim, P., Freeman, G. J., Sharpe, A. H., and Lichtman, A. H. (2011). Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation. Arterioscler. Thromb. Vasc. Biol. 31, 1100-1107.
10. Buono, C., Pang, H., Uchida, Y., Libby, P., Sharpe, A. H., and Lichtman, A. H. (2004). B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 109, 2009-2015.
11. Chavez-Sanchez, L., Madrid-Miller, A., Chavez-Rueda, K., Legorreta-Haquet, M. V., Tesoro-Cruz, E., and Blanco-Favela, F. (2010). Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and mono-cytes triggers the inflammatory response. Hum. Immunol. 71, 737-744.
12. Choi, J. H., Cheong, C., Dandamudi, D. B., Park, C. G., Rodriguez, A., Mehandru, S., Velinzon, K., Jung, I. H., Yoo, J. Y., Oh, G. T., and Stein-man, R. M. (2011). Flt3 signaling-dependent dendritic cells protect against atherosclerosis. Immunity 35, 819-831.
13. Choi, S. H., Harkewicz, R., Lee, J. H., Boullier, A., Almazan, F., Li, A. C., Witztum, J. L., Bae, Y. S., and Miller, Y. I. (2009). Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ. Res. 104, 1355-1363.
14. Curtis, J. R., and Singh, J. A. (2011). Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin. Ther. 33, 679-707.
15. Cybulsky, M. I., and Jongstra-Bilen, J. (2010). Resident intimal dendritic cells and the initiation of atherosclerosis. Curr. Opin. Lipidol. 21, 397-403.
16. de Boer, O. J., Hirsch, F., van der Wal, A. C., van der Loos, C. M., Das, P. K., and Becker, A. E. (1997). Costim-ulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. Atherosclerosis 133, 227-234.
17. Ford, M. L., and Larsen, C. P. (2009). Translating costimulation blockade to the clinic: lessons learned from three pathways. Immunol. Rev. 229, 294-306.
18. Fortun, A., Khalil, A., Gagne, D., Douziech, N., Kuntz, C., Jay-Gerin, J. P., Dupuis, G., and Fulop, T. Jr. (2001). Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation. Atherosclerosis 156, 11-21.
19. Francisco, L. M., Sage, P. T., and Sharpe, A. H. (2010). The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236, 219-242.
20. Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., and Sharpe, A. H. (2009). PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206, 3015-3029.
21. Furukawa, Y., Mandelbrot, D. A., Libby, P., Sharpe, A. H., and Mitchell, R. N. (2000). Association of B7-1 co-stimulation with the development of graft arterial disease. Studies using mice lacking B7-1, B7-2, or B7-1/B7-2. Am. J. Pathol. 157, 473-484.
22. Gerdes, N., and Zirlik, A. (2011). Co-stimulatory molecules in and beyond co-stimulation - tipping the balance in atherosclerosis? Thromb. Haemost. 106, 804-813.
23. Giubilato, S., Liuzzo, G., Brugaletta, S., Pitocco, D., Graziani, F., Smal-done, C., Montone, R. A., Pazzano, V., Pedicino, D., Biasucci, L. M., Ghirlanda, G., and Crea, F. (2011). Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur. Heart J. 32, 1214-1226.
24. Gotsman, I., Grabie, N., Dacosta, R., Sukhova, G., Sharpe, A., and Licht-man, A. H. (2007). Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. J. Clin. Invest. 117, 2974-2982.
25. Gotsman, I., Grabie, N., Gupta, R., Dacosta, R., MacConmara, M., Led-erer, J., Sukhova, G., Witztum, J. L., Sharpe, A. H., and Lichtman, A. H. (2006). Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 114, 2047-2055.
26. Gotsman, I., Sharpe, A. H., and Licht-man, A. H. (2008). T-cell costimula-tion and coinhibition in atherosclerosis. Circ. Res. 103, 1220-1231.
27. Grabie, N., Gotsman, I., DaCosta, R., Pang, H., Stavrakis, G., Butte, M. J., Keir, M. E., Freeman, G. J., Sharpe, A. H., and Lichtman, A. H. (2007). Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart. Circulation 116, 2062-2071.
28. Grewal, I. S., and Flavell, R. A. (1998). CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16, 111-135.
29. Harrison, D. G., Vinh, A., Lob, H., and Madhur, M. S. (2010). Role of the adaptive immune system in hypertension. Curr. Opin. Pharmacol. 10, 203-207.
30. Heath, W. R., and Carbone, F. R. (2009). Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10, 1237-1244.
31. Herber, D. L., Cao, W., Nefedova, Y., Novitskiy, S. V., Nagaraj, S., Tyurin, V. A., Corzo, A., Cho, H. I., Celis, E., Lennox, B., Knight, S. C., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., Antonia, S., Fishman, M., Ferris, R. L., Kagan, V. E., and Gabrilovich, D. I. (2010). Lipid accumulation and dendritic cell dysfunction in cancer. Nat. Med. 16, 880-886.
32. Hermansson, A., Johansson, D. K., Ketelhuth, D. F., Andersson, J., Zhou, X., and Hansson, G. K. (2011). Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation 123, 1083-1091.
33. Hermansson, A., Ketelhuth, D. F., Strodthoff, D., Wurm, M., Hans-son, E. M., Nicoletti, A., Paulsson-Berne, G., and Hansson, G. K. (2010). Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J. Exp. Med. 207, 1081-1093.
34. Inder, S. J., Bobryshev, Y. V., Cher-ian, S. M., Lord, R. S., Masuda, K., and Yutani, C. (2000a). Accumulation of lymphocytes, dendritic cells, and granulocytes in the aortic wall affected by Takayasu's disease. Angiology 51, 565-579.
35. Inder, S. J., Bobryshev, Y. V., Cherian, S. M., Wang, A. Y., Lord, R. S., Masuda, K., and Yutani, C. (2000b). Immunophenotypic analysis of the aortic wall in Takayasu's arteri-tis: involvement of lymphocytes, dendritic cells and granulocytes in immuno-inflammatoryreactions. Cardiovasc. Surg. 8, 141-148.
36. Ishii, N., Takahashi, T., Soroosh, P., and Sugamura, K. (2010). OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Adv. Immunol. 105, 63-98.
37. Jeon, H. J., Choi, J. H., Jung, I. H., Park, J. G., Lee, M. R., Lee, M. N., Kim, B., Yoo, J. Y., Jeong, S. J., Kim, D. Y., Park, J. E., Park, H. Y., Kwack, K., Choi, B. K., Kwon, B. S., and Oh, G. T. (2010). CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice. Circulation 121, 1124-1133.
38. Josefowicz, S. Z., Lu, L. F., and Rudensky, A. Y. (2012). Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. [Epub ahead of print].
39. Ketelhuth, D. F., and Hansson, G. K. (2011). Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall. Thromb. Haemost. 106, 779-786.
40. Kim, K. S., Denton, M. D., Chandraker, A., Knoflach, A., Milord, R., Waaga, A. M., Turka, L. A., Russell, M. E., Peach, R., and Sayegh, M. H. (2001). CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis. Am. J. Pathol. 158, 977-986.
41. Kim, W. J., Bae, E. M., Kang, Y. J., Bae, H. U., Hong, S. H., Lee, J. Y., Park, J. E., Kwon, B. S., Suk, K., and Lee, W. H. (2006). Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques. Immunology 119, 421-429.
42. Koga, N., Suzuki, J., Kosuge, H., Haraguchi, G., Onai, Y., Futamatsu, H., Maejima, Y., Gotoh, R., Saiki, H., Tsushima, F., Azuma, M., and Isobe, M. (2004). Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts. Arterioscler. Thromb. Vasc. Biol. 24, 2057-2062.
43. Krupa, W. M., Dewan, M., Jeon, M. S., Kurtin, P. J., Younge, B. R., Goronzy, J. J., and Weyand, C. M. (2002). Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis. Am. J. Pathol. 161, 1815-1823.
44. Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., Winn, K. J., and Pearson, T. C. (1996). Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438.
45. Lee, J., Zhuang, Y., Wei, X., Shang, F., Wang, J., Zhang, Y., Liu, X., Yang, Y., Liu, L., and Zheng, Q. (2009). Contributions of PD-1/PD-L1 pathway to interactions of myeloid DCs with T cells in atherosclerosis. J. Mol. Cell. Cardiol. 46, 169-176.
46. Lehman, T. J., Walker, S. M., Mahnovski, V., and McCurdy, D. (1985). Coronary arteritis in mice following the systemic injection of group B Lac-tobacillus casei cell walls in aqueous suspension. Arthritis Rheum. 28, 652-659.
47. Lievens, D., Eijgelaar, W. J., Biessen, E. A., Daemen, M. J., and Lutgens, E. (2009). The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb. Haemost. 102, 206-214.
48. Liuzzo, G., Biasucci, L. M., Trotta, G., Brugaletta, S., Pinnelli, M., Digian-uario, G., Rizzello, V., Rebuzzi, A. G., Rumi, C., Maseri, A., and Crea, F. (2007). Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. J. Am. Coll. Cardiol. 50, 1450-1458.
49. Lutgens, E., Gorelik, L., Daemen, M. J., de Muinck, E. D., Grewal, I. S., Koteliansky, V. E., and Flavell, R. A. (1999). Requirement for CD154 in the progression of atherosclerosis. Nat. Med. 5, 1313-1316.
50. Mach, F., Schonbeck, U., Sukhova, G. K., Atkinson, E., and Libby, P. (1998). Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394, 200-203.
51. Ma-Krupa, W., Jeon, M.-S., Spoerl, S., Tedder, T. F., Goronzy, J. J., and Weyand, C. M. (2004). Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J. Exp. Med. 199, 173-183.
52. Maldonado, R. A., and von Andrian, U. H. (2010). How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol. 108, 111-165.
53. Miga, A., Masters, S., Gonzalez, M., and Noelle, R. J. (2000). The role of CD40-CD154 interactions in the regulation of cell mediated immunity. Immunol. Invest. 29, 111-114.
54. Miller, Y. I., Choi, S.-H., Wiesner, P., Fang, L., Harkewicz, R., Hartvigsen, K., Boullier, A., Gonen, A., Diehl, C. J., Que, X., Montano, E., Shaw, P. X., Tsimikas, S., Binder, C. J., and Witztum, J. L. (2011). Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res. 108, 235-248.
55. Mitchell, R. N., and Libby, P. (2007). Vascular remodeling in transplant vasculopathy. Circ. Res. 100, 967-978.
56. Moore, K. J., and Tabas, I. (2011). Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341-355.
57. Munroe, M. E. (2009). Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis. Semin. Immunol. 21, 283-288.
58. Murray, P. J., and Wynn, T. A. (2011). Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737.
59. Nakano, M., Fukumoto, Y., Satoh, K., Ito, Y., Kagaya, Y., Ishii, N., Sugamura, K., and Shimokawa, H. (2010). OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovas-cularization. Cardiovasc. Res. 88, 539-546.
60. Nickel, T., Schmauss, D., Hanssen, H., Sicic, Z., Krebs, B., Jankl, S., Summo, C., Fraunberger, P., Walli, A. K., Pfeiler, S., and Weis, M. (2009). oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation. Atherosclerosis 205, 442-450.
61. Olofsson, P. S., Soderstrom, L. A., Jern, C., Sirsjo, A., Ria, M., Sundler, E., de Faire, U., Wiklund, P. G., Ohrvik, J., Hedin, U., Paulsson-Berne, G., Hamsten, A., Eriksson, P., and Hansson, G. K. (2009). Genetic variants of TNFSF4 and risk for carotid artery disease and stroke. J. Mol. Med. (Berl.) 87, 337-346.
62. Olofsson, P. S., Soderstrom, L. A., Wagsater, D., Sheikine, Y., Ocaya, P., Lang, F., Rabu, C., Chen, L., Rudling, M., Aukrust, P., Hedin, U., Paulsson-Berne, G., Sirsjo, A., and Hansson, G. K. (2008). CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercho-lesterolemic mice. Circulation 117, 1292-1301.
63. Onishi, Y., Fehervari, Z., Yamaguchi, T., and Sakaguchi, S. (2008). Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. U.S.A. 105, 10113-10118.
64. Packard, R. R., Maganto-Garcia, E., Gotsman, I., Tabas, I., Libby, P., and Lichtman, A. H. (2008). CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis. Circ. Res. 103, 965-973.
65. Paulson, K. E., Zhu, S.-N., Chen, M., Nurmohamed, S., Jongstra-Bilen, J., and Cybulsky, M. I. (2010). Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ. Res. 106, 383-390.
66. Randolph, G. J. (2008). Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis. Curr. Opin. Lipidol. 19, 462-468.
67. Rodig, N., Ryan, T., Allen, J. A., Pang, H., Grabie, N., Chernova, T., Greenfield, E. A., Liang, S. C., Sharpe, A. H., Lichtman, A. H., and Freeman, G. J. (2003). Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur. J. Immunol. 33, 3117-3126.
68. Schmidt, D., Goronzy, J. J., and Weyand, C. M. (1996). CD4+ CD7- CD28-T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J. Clin. Invest. 97, 2027-2037.
69. Schonbeck, U., Sukhova, G. K., Shimizu, K., Mach, F., and Libby, P. (2000). Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc. Natl. Acad. Sci. U.S.A. 97, 7458-7463.
70. Schulte, D. J., Yilmaz, A., Shimada, K., Fishbein, M. C., Lowe, E. L., Chen, S., Wong, M., Doherty, T. M., Lehman, T., Crother, T. R., Sorrentino, R., and Arditi, M. (2009). Involvement of innate and adaptive immunity in a murine model of coronary arteri-tis mimicking Kawasaki disease. J. Immunol. 183, 5311-5318.
71. Shamshiev, A. T., Ampenberger, F., Ernst, B., Rohrer, L., Marsland, B. J., and Kopf, M. (2007). Dyslipi-demia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity. J. Exp. Med. 204, 441-452.
72. Sharpe, A. H. (2009). Mechanisms of costimulation. Immunol. Rev. 229, 5-11.
73. Shevach, E. M. (2009). Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30, 636-645.
74. Snyder, M. R., Nakajima, T., Leibson, P. J., Weyand, C. M., and Goronzy, J. J. (2004). Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms. J. Immunol. 173, 3725-3731.
75. Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., and Hansson, G. K. (1995). T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipopro-tein. Proc. Natl. Acad. Sci. U.S.A. 92, 3893-3897.
76. Tabas, I., Williams, K. J., and Boren, J. (2007). Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116, 1832-1844.
77. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., and Sharpe, A. H. (1995). Loss of CTLA-4 leads to massive lympho-proliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
78. Topalian, S. L., Weiner, G. J., and Pardoll, D. M. (2011). Cancer immunother-apy comes of age. J. Clin. Oncol. 29, 4828-4836.
79. van Olffen, R. W., de Bruin, A. M., Vos, M., Staniszewska, A. D., Hamann, J., van Lier, R. A., de Vries, C. J., and Nolte, M. A. (2010). CD70-driven chronic immune activation is protective against atherosclerosis. J. Innate Immun. 2, 344-352.
80. van Wanrooij, E. J., van Puijvelde, G. H., de Vos, P., Yagita, H., van Berkel, T. J., and Kuiper, J. (2007). Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27, 204-210.
81. Vinh, A., Chen, W., Blinder, Y., Weiss, D., Taylor, W. R., Goronzy, J. J., Weyand, C. M., Harrison, D. G., and Guzik, T. J. (2010). Inhibition and genetic ablation of the B7/CD28 T-cell cos-timulation axis prevents experimental hypertension. Circulation 122, 2529-2537.
82. Wang, X., Ria, M., Kelmenson, P. M., Eriksson, P., Higgins, D. C., Sam-negard, A., Petros, C., Rollins, J., Bennet, A. M., Wiman, B., de Faire, U., Wennberg, C., Olsson, P. G., Ishii, N., Sugamura, K., Hamsten, A., Forsman-Semb, K., Lagercrantz, J., and Paigen, B. (2005). Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat. Genet. 37, 365-372.
83. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahin-ian, A., Lee, K. P., Thompson, C. B., Griesser, H., and Mak, T. W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988.
84. Weber, C., Meiler, S., Doring, Y., Koch, M., Drechsler, M., Megens, R. T., Rowinska, Z., Bidzhekov, K., Fecher, C., Ribechini, E., van Zandvoort, M. A., Binder, C. J., Jelinek, I., Hris-tov, M., Boon, L., Jung, S., Korn, T., Lutz, M. B., Forster, I., Zenke, M., Hieronymus, T., Junt, T., and Zernecke, A. (2011). CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J. Clin. Invest. 121, 2898-2910.
85. Wekerle, T., Kurtz, J., Bigenzahn, S., Takeuchi, Y., and Sykes, M. (2002). Mechanisms of transplant tolerance induction using costimulatory blockade. Curr. Opin. Immunol. 14, 592-600.
86. Wing, K., Yamaguchi, T., and Sakaguchi, S. (2011). Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation. Trends Immunol. 32, 428-433.
87. Yilmaz, A., Rowley, A., Schulte, D. J., Doherty, T. M., Schroder, N. W., Fishbein, M. C., Kalelkar, M., Cicha, I., Schubert, K., Daniel, W. G., Garlichs, C. D., and Arditi, M. (2007). Activated myeloid dendritic cells accumulate and co-localize with CD3+ CD3 T cells in coronary artery lesions in patients with Kawasaki disease. Exp. Mol. Pathol. 83, 93-103.
88. Zal, B., Kaski, J. C., Arno, G., Akiyu, J. P., Xu, Q., Cole, D., Whelan, M., Russell, N., Madrigal, J. A., Dodi, I. A., and Baboonian, C. (2004). Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes. Circulation 109, 1230-1235.